MedPath

resTORbio, Inc.

resTORbio, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2016-01-01
Employees
1
Market Cap
-
Website
https://www.restorbio.com

A Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly

Phase 3
Completed
Conditions
Respiratory Tract Infections
Interventions
Other: Placebo
First Posted Date
2020-12-16
Last Posted Date
2021-06-23
Lead Sponsor
Restorbio Inc.
Target Recruit Count
1024
Registration Number
NCT04668352
Locations
🇳🇿

P3 Research Ltd., Wellington, New Zealand

A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

Phase 2
Active, not recruiting
Conditions
Covid19
Interventions
Drug: Placebo
First Posted Date
2020-10-14
Last Posted Date
2021-02-09
Lead Sponsor
Restorbio Inc.
Target Recruit Count
60
Registration Number
NCT04584710
Locations
🇺🇸

Hebrew Senior Life, Marcus Institute for Aging Research, Roslindale, Massachusetts, United States

🇺🇸

University of Connecticut, UConn Center on Aging, Farmington, Connecticut, United States

Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes

Phase 2
Terminated
Conditions
COVID19
Interventions
Drug: Placebo
First Posted Date
2020-06-01
Last Posted Date
2021-02-10
Lead Sponsor
Restorbio Inc.
Target Recruit Count
36
Registration Number
NCT04409327
Locations
🇺🇸

Nursing Home, Middletown, Rhode Island, United States

Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly

Phase 3
Withdrawn
Conditions
Clinically Symptomatic Respiratory Illness
Interventions
Drug: Placebo
First Posted Date
2019-10-25
Last Posted Date
2019-11-22
Lead Sponsor
Restorbio Inc.
Registration Number
NCT04139915

Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly

Phase 2
Active, not recruiting
Conditions
Respiratory Tract Infections
Interventions
Other: Placebo
Drug: BEZ235 plus everolimus (RAD001)
First Posted Date
2017-12-14
Last Posted Date
2018-05-16
Lead Sponsor
Restorbio Inc.
Target Recruit Count
652
Registration Number
NCT03373903
Locations
🇺🇸

Heartland Research Associates, Wichita, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath